Natural Beauty Bio-Technology (NBBTF) Financial Statements
Natural Beauty Bio-Technology Financial Overview
Natural Beauty Bio-Technology's market cap is currently $112.28M. The company's EPS TTM is $-0.03; its P/E ratio is -15.33; and it has a dividend yield of 0.48%. Natural Beauty Bio-Technology has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 538.83M | $ 353.65M | $ 336.01M | $ 335.88M | $ 487.81M |
| Gross Profit | $ 293.34M | $ 202.33M | $ 200.34M | $ 165.33M | $ 281.80M |
| Operating Income | $ 23.18M | $ -97.16M | $ -3.74M | $ -19.20M | $ 50.48M |
| EBITDA | $ 66.15M | $ -65.50M | $ 22.91M | $ 15.09M | $ 85.23M |
| Net Income | $ 10.58M | $ -103.61M | $ -15.11M | $ -30.47M | $ 35.26M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 112.12M | $ 116.51M | $ 166.81M | $ 168.61M | $ 197.08M |
| Total Assets | $ 931.55M | $ 772.93M | $ 882.58M | $ 883.53M | $ 937.16M |
| Total Debt | $ 319.30M | $ 212.13M | $ 186.29M | $ 143.48M | $ 129.07M |
| Net Debt | $ 215.00M | $ 95.62M | $ 27.54M | $ -17.11M | $ -59.14M |
| Total Liabilities | $ 457.56M | $ 325.34M | $ 308.06M | $ 286.07M | $ 279.24M |
| Stockholders' Equity | $ 473.98M | $ 447.59M | $ 574.52M | $ 597.46M | $ 657.92M |
| Cash Flow | |||||
| Free Cash Flow | $ -93.91M | $ -54.96M | $ -47.39M | $ -35.98M | $ 4.67M |
| Operating Cash Flow | $ -25.66M | $ -13.75M | $ 21.72M | $ 11.56M | $ 42.78M |
| Investing Cash Flow | $ -68.95M | $ -40.17M | $ -67.61M | $ -38.77M | $ -31.21M |
| Financing Cash Flow | $ 84.61M | $ 15.34M | $ 42.63M | $ 13.21M | $ 10.42M |
Currency in HKD